Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: MGV who wrote (3961)	7/26/2000 11:58:04 AM
From: kolo55	Read Replies (1) \| Respond to of 4140

My average cost is around 7 1/4... ...but I am lowering that cost a lot today. I am buying this stock with both hands now. This morning IBD published a front page article comparing VISX and SNRS over the last two years. The article didn't discuss the fact that the two products are essentially for different markets, that SNRS was waiting for FDA approval, and that the FDA approval is now in-hand. In summary, a terribly misleading article. Whoever dumped just before the close last night apparently had foreknowledge of this article (IBD has a major leak somewhere). I didn't hold the stock two years ago, and even though I first looked at it in April 1999, I passed as too risky at the price of 13-14 at that time. I waited and bided my time until SNRS passed the ODP hurdle in January, and sold off to a reasonable risk/reward price in late February. Then I held off until FDA approval was in hand to add to my position. But now, the price is very attractive, and I am scooping up shares, over 20k today. I don't let my buying be more than a certain fraction of the shares traded in a single day, so I will likely be buying more tomorrow if it is still selling at fire sale prices. Paul